Vilfuro-G Capsule is a combination medication used in the management of chronic obstructive pulmonary disease (COPD). It contains three active ingredients:

• Fluticasone Furoate (100mcg): A corticosteroid that reduces inflammation in the airways.

• Glycopyrronium (50mcg): An anticholinergic agent that relaxes airway muscles and decreases mucus production.

• Vilanterol (25mcg): A long-acting beta-agonist (LABA) that helps to keep air passages open by relaxing the muscles around them.

This combination works synergistically to improve lung function, alleviate symptoms like breathlessness, and reduce the risk of COPD exacerbations.

Usage Instructions:

• Dosage: As prescribed by your healthcare provider.

• Administration: Typically administered via inhalation. Follow the instructions provided with the inhaler device to ensure correct usage.

• Frequency: Usually once daily, at the same time each day, or as directed by your doctor.

Common Side Effects:

• Nasopharyngitis (inflammation of the throat and nasal passages)

• Upper respiratory tract infection

• Fungal infection of the mouth (oral thrush)

• Headache

To minimize the risk of oral thrush, rinse your mouth with water after each inhalation.

Precautions:

• Allergies: Inform your doctor if you have any known allergies to the components of this medication.

• Medical Conditions: Discuss your medical history, especially if you have liver or kidney disease, with your healthcare provider.

• Pregnancy and Breastfeeding: Consult your doctor before using this medication if you are pregnant, planning to become pregnant, or breastfeeding.

Note: Always use Vilfuro-G Capsule as directed by your healthcare provider. Do not discontinue use abruptly without consulting your doctor, as this may worsen your condition. Regular follow-ups are essential to monitor your response to the treatment and make necessary adjustments.